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Abstract
The type I interferon (IFN) system is a first line of defense against viral infections. Viruses have developed various mechanisms
to counteract this response. So far, the interferon antagonistic activity of influenza A viruses was mainly observed on the level
of IFNb gene induction via action of the viral non-structural protein 1 (NS1). Here we present data indicating that influenza A
viruses not only suppress IFNb gene induction but also inhibit type I IFN signaling through a mechanism involving induction
of the suppressor of cytokine signaling-3 (SOCS-3) protein. Our study was based on the observation that in cells that were
infected with influenza A virus and subsequently stimulated with IFNa/b, phosphorylation of the signal transducer and
activator of transcription protein 1 (STAT1) was strongly reduced. This impaired STAT1 activation was not due to the action of
viral proteins but rather appeared to be induced by accumulation of viral 59 triphosphate RNA in the cell. SOCS proteins are
potent endogenous inhibitors of Janus kinase (JAK)/STAT signaling. Closer examination revealed that SOCS-3 but not SOCS-1
mRNA levels increase in an RNA- and nuclear factor kappa B (NF-kB)-dependent but type I IFN-independent manner early in
the viral replication cycle. This direct viral induction of SOCS-3 mRNA and protein expression appears to be relevant for
suppression of the antiviral response since in SOCS-3 deficient cells a sustained phosphorylation of STAT1 correlated with
elevated expression of type I IFN-dependent genes. As a consequence, progeny virus titers were reduced in SOCS-3 deficient
cells or in cells were SOCS-3 expression was knocked-down by siRNA. These data provide the first evidence that influenza A
viruses suppress type I IFN signaling on the level of JAK/STAT activation. The inhibitory effect is at least in part due to the
induction of SOCS-3 gene expression, which results in an impaired antiviral response.
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Introduction
Influenza A viruses are negative-stranded RNA viruses that
belong to the family oforthomyxoviruses. The segmented genome of
influenza A virus encodes for up to 11 viral proteins. As many other
viruses, influenza viruses have evolved strategies to counteract
cellular antiviral responses, especially to circumvent the type I IFN
system as a first line of defense against the pathogenic invader.
Among the influenza viral proteins, the NS1 has been identified
as the main type I IFN antagonistic factor. So far two major
mechanisms have been described by which NS1 suppresses the
initial expression of IFNb. On the one hand NS1 inhibits vRNA-
mediated induction of the transcription factors interferon
regulatory factor-3 (IRF-3), activating protein–1 (AP-1) and NF-
kB that target the IFNb promoter. This most likely occurs via
binding to the RNA-sensor retinoic acid inducible gene (RIG-I)
and inhibition of RIG-I-mediated signaling in response to viral
RNA [1,2]. On the other hand NS1 inhibits maturation [3,4] and
nuclear export of host mRNAs [5]. Other functions of the
multifunctional protein include block of activation of the dsRNA-
activated protein kinase PKR by direct interaction [6] or
activation of the phosphatidylinositol-3 kinase PI3K/Akt pathway
to prevent premature apoptosis induction [7,8].
While the NS1-mediated antagonistic activities of influenza
viruses mainly affect the induction of genes such as IFNb, so far no
viral suppression of IFN signaling has been described.
IFN are among the first molecules synthesized in response to viral
infections[9].TheIFNfamilyincludesthreeclasses.TypeIcomprises
the well known IFNa and IFNb. The only member of type II IFN is
IFNc.Type IIIIFNcomprisesIFNl1,-l2, and -l3. Allclasses of IFN
bind to different receptors and are structurally not related [10,11].
Type I IFN belong to the key cytokines produced by influenza A
virus-infected epithelial cells [12,13]. The antiviral activity of type I
IFN is mediated by a set of IFN-induced genes (ISGs).
Binding of IFNa/b to its receptor is the initial step in this
signaling process, followed by activation of the JAK family and
subsequent activation of STAT proteins [14].
Ligand binding leads to dimerisation of the type I IFN receptor
subunits IFNAR1 and IFNAR2 and causes their conformational
change. The JAK kinase Tyk2, which is constitutively bound to
IFNAR1, phosphorylates the receptor at tyrosine residues and
creates a docking site for STAT2. Subsequently, Tyk2 phosphor-
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JAK1 phosphorylates STAT1 at Y701 [15,16].
The phosphorylated transcription factors dimerise and bind to
IRF-9 [17]. The newly formed heterotrimer, called IFN-
stimulated gene factor 3 (ISGF3), translocates into the nucleus
and binds to IFN-stimulated response elements (ISRE), to initiate
gene transcription of ISGs. Treatment of cells with type I IFN up-
regulates expression of an array of genes including SP110, IRF-1
and many others [18]. Among these ISGs the 29,5 9 -
oligoadenylate synthetase 1 (OAS1), the Mx proteins and the
dsRNA-activated protein kinase (PKR) are described to directly
interfere with viral replication [19]. Both, PKR and the OAS1/
RNaseL system are capable of inhibiting cellular and viral
translation.
IFN-induced JAK/STAT signaling can be inhibited at different
levels by several viral and cellular factors through various
mechanisms. The large T-antigen of murine polyomavirus
(MPyV) binds to JAK1 and inhibits downstream signaling [20],
whereas the VP24 of Ebola virus (EBOV) binds to karyopherina-1
thereby blocking nuclear accumulation of STAT1 [21].
Endogenous cellular key regulators, capable of negatively
regulating JAK/STAT-mediated signal transduction, include
suppressor of cytokine signaling (SOCS) proteins, protein tyrosine
phosphatases (PTP) and protein inhibitor of activated STATs
(PIAS). The family of SOCS proteins comprises eight members
(cytokine-inducible SH2 domain-containing protein (CIS) and
SOCS1-7). All members contain a central SH2 domain, an N-
terminus of variable length and sequence and a C-terminal 40
amino-acid module called SOCS box [22]. The SOCS box is
necessary for recruitment of the ubiquitin transferase system and
for stabilization and/or degradation of SOCS proteins [23–25].
The N-terminus contains a kinase inhibitory region (KIR), which
functions as pseudo substrate for the JAK [26]. SOCS-1 and
SOCS-3 differ in their mode of action. For inhibition of the kinase
activity of JAKs, SOCS-1 binds directly to the activation loop of
JAKs [26–28]. In contrast, SOCS-3 first binds to the receptor
[29,30].
Induction of SOCS-3 gene transcription by viruses was reported
for HSV-1, HCV [31–33] and for respiratory viruses, such as
SARS and RSV [34,35]. The level of induction of SOCS-3
by HSV-1 seems to determine whether infection turns to acute
or persistent progression [31]. For HCV it has been suggested
that upregulation of SOCS-3 may contribute to the non-respon-
siveness of HCV patients to IFN therapy [33,36–38]. Elevated
SOCS-3 mRNA levels during RSV infection were linked to Th2
cell-mediated immune disease as atopic dermatitis and asthma
[39,40].
In the present study we show that influenza A virus can be
added to the list of viruses that induce SOCS-3 expression. The
protein functionally interferes with viral replication by providing a
virus-supportive IFN-antagonistic activity on the level of type I
IFN-signaling that has not been described so far.
Results
IFNa/b but not IFNc-induced STAT phosphorylation is
inhibited in influenza A virus infected cells
Phosphorylation of STAT1 and STAT2 by members of the
JAK tyrosine kinase family is a prerequisite for activation of
these transcription factors to drive type I IFN-induced gene
expression. Therefore, we analyzed whether STAT phosphor-
ylation patterns are altered in influenza A virus infected cells
that were stimulated with IFN at different time points post
infection (p.i.). The human alveolar epithelial cell line A549 was
infected with the influenza A virus strain A/Puerto-Rico/8/34
(H1N1) (PR8) (Figure 1A). Cells were subsequently stimulated
with IFNb at given time-points p.i. and STAT phosphorylation
was assessed in Western blots. Both STAT1 and STAT2 were
readily phosphorylated upon cytokine stimulation in uninfected
cells or in infected cells up to 4 h p.i. (Figure 1A). Furthermore,
virus infection alone resulted in a significant induction of STAT
phosphorylation 4–6 h p.i., presumably caused by virus-induced
IFN expression. However, at later time points (6–10 h p.i.), in
A549 cells both virus- and IFN-induced STAT1 and STAT2
phosphorylation was markedly reduced (Figure 1A). Similar
patterns were observed upon stimulation of cells with IFNa or
upon infection with other viruses, such as the human influenza
virus A/Victora/3/75 (H3N2) (data not shown). In addition,
this phenomenon could also be detected in other epithelial cells
such as the human embryonic kidney cell line HEK293
(Figure 2E) or the human umbilical vein endothelial cells
(HUVEC) (Figure S1B). Inhibition was not caused by indirect
disturbing effects on cellular metabolism or enzyme activities
due to ongoing virus replication, since IFNc-induced STAT1
phosphorylation was not affected at all (Figure 1C). Finally,
involvement of any auto- or paracrine action of virus-induced
type I IFN could be ruled out, as the inhibitory effect was also
observed in Vero cells lacking functional type I IFN genes
(Figure 1E).
Forced expression of influenza virus proteins does not
result in reduced STAT1 phosphorylation
With regard to the molecular basis of impaired IFNa/b-induced
STAT phosphorylation in infected cells it was striking that the
inhibitory effect correlated with the accumulation of viral proteins,
as monitored in PB1 Western blots (Figures 1A and 1E). Thus, the
question arose whether individual expression of viral proteins may
result in the interference with STAT1 phosphorylation. Out of the
11 viral proteins of PR8 we choose the nucleoprotein (NP), the
NS1 protein, the matrix protein (M1) (Figure 2A) and the subunits
of the viral polymerase, PA, PB1 and PB2 (Figure 2C), for a
representative experiment. These proteins are known to bind to
vRNA/RNPs or to interfere with the RNA-mediated innate
immune response. For efficient transfection of the expression
Author Summary
The type I interferon (IFN) system is one of the most
powerful innate defenses against viral pathogens. Most
RNA viruses are sensitive to the action of type I IFN.
Therefore, these pathogens have evolved strategies to
evade this response. For example, influenza viruses express
a viral protein, the non-structural protein 1 (NS1), that
suppresses production of IFNb by lowering cellular
sensitivity to viral nucleic acid as a pathogen pattern.
Here we present data indicating that influenza A viruses
are not only capable of suppressing production of the IFNb
gene but also inhibit action of this antiviral cytokine on
cells. This occurs by viral induction of a cellular protein, the
suppressor of cytokine signaling (SOCS)-3, a potent
endogenous inhibitor of IFN signaling. This is a novel
mechanism by which influenza viruses inhibit the antiviral
response of the host and paves the path to efficient virus
replication. This may be especially relevant for influenza
viruses that induce high cytokine responses (cytokine
burst), such as highly pathogenic avian influenza viruses of
the H5N1 subtype. Induction of SOCS-3 expression would
allow efficient replication despite high IFN and cytokine
levels.
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also exhibits impaired IFNb-induced STAT1 phosphorylation
at later stages of infection (Figure 2E). 24 h post transfection
cells were stimulated with IFNb and STAT phosphorylation was
monitored in Western blots (Figures 2A and C). Expression of
none of the viral proteins resulted in a significant decrease of
IFNb-induced STAT1 or STAT2 phosphorylation (Figures 2A
and 2C). Similar results were obtained in the human bronchial
epithelial cell line H1299 when expressing M1, NS1 or NP
alone or in different combinations (data not shown). Thus, we
concluded that viral proteins most likely do not play a
prominent role as blockers of IFNa/b-induced JAK/STAT
signaling.
Impaired STAT1 phosphorylation is not mediated by
virus-induced phosphatases
Decrease of STAT phosphorylation might also be due to the
action of virus-induced phosphatases. On the one hand these
enzymes may cause direct dephosphorylation of STAT proteins.
On the other hand phosphatases could act via an indirect
mechanism by dephosphorylation and inactivation of JAKs
resulting in an attenuated phosphorylation of STATs. Several
protein tyrosine phosphatases (PTPs) are known to mediate
dephosphorylation of both, JAKs and STATs [41]. In order to
investigate whether influenza A virus activates phosphatases that
subsequently target JAKs or STATs, we treated infected or
uninfected A549 cells with the well-known tyrosine phosphatase
inhibitor sodium vanadate [42,43]. Uninfected cells or cells
infected with PR8 for 10 h were incubated with increasing
amounts of this compound 10 min prior to stimulation with
IFNb. This time point of infection was chosen since we observed
considerable inhibition of IFN-induced STAT1 phosphorylation
in the course of infection (Figures 1A and 1E). Increasing
concentrations of vanadate lead to a gradual shift of the steady
state balance of phosphorylation/dephosphorylation. Accord-
ingly, a gradual increase of STAT1 phosphorylation was
observed that was similar in both infected and uninfected cells,
albeit starting from different basal levels of phospho-STAT1
(Figures 3A and B). This is illustrated by an almost identical
slope of the regression line in the graphical analysis of the band
intensities of the IFNb stimulated samples (Figure 3B). If the
blockade of IFNb-induced STAT1 phosphorylation would be
mediated by specific virus-activated phosphatases, a much
steeper slope for vanadate-treated infected cells would be
expected. However, the result in Figure 3B indicates that the
virus-induced suppression of phosphorylation is not compensat-
ed by phosphatase inhibition and consequently no virus-
activated phosphatase appears to be involved. In support of
these data, phosphatase assays revealed that the overall activity
of tyrosine phosphatases in infected cells was not elevated
compared to uninfected cells. This is indicated by constant levels
of free phosphates released from two different phospho-peptides
that represent common tyrosine phosphatase substrates
(Figure 3C). Thus, involvement of phosphatases in influenza
Figure 1. Influenza virus infection results in impaired IFNb-induced STAT1 and STAT2 phosphorylation. A549 (A, C) or Vero cells (E)
were infected with the human influenza virus PR8 (H1N1) (MOI=5) for the indicated time points and were subsequently stimulated for 15 min with
either human IFNb at a concentration of 100 U/ml (A) or 500 U/ml (E) or human IFNc 500 U/ml (C). Cells were lysed and cell extracts were separated
by SDS-PAGE and blotted onto nitrocellulose membranes. Membranes were incubated with anti-phospho-STAT1, anti-STAT1, anti-phospho-STAT2
and anti-PB1 antibodies in Western blots. (B, D, F) Quantification of relative pSTAT1 and pSTAT2 band intensities in A, C and E using AIDA software
and 2D densitometry (Fuji).
doi:10.1371/journal.ppat.1000196.g001
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greatly ruled out.
Influenza virus infection results in the induction of SOCS-
3 mRNA expression
Phosphorylation of STATs in the IFNb signaling cascade may
not only be counter-regulated by phosphatases but also by other
cellular factors, such as proteins of the suppressors of cytokine
signaling (SOCS) family. Action of these proteins is mainly
controlled on the level of transcriptional activation. SOCS proteins
are described to have high affinity for JAK and STAT proteins
and to inhibit the transmission of IFNa and IFNb induced
signaling [44,45]. To examine whether expression of SOCS genes
is induced in influenza virus infected cells, A549 cells were infected
with PR8 for different time points. Subsequently total RNA was
analyzed for the amount of SOCS-1 and SOCS-3 mRNA by
means of quantitative real time-PCR (qRT-PCR). The mRNA
Figure 2. Forced expression of influenza viral proteins does not result in impaired IFNb-induced STAT1 and STAT2
phosphorylation. HEK293 cells were transfected with 500 ng plasmid DNA for expression of viral NP, M, NS, (A) PA, PB1 and PB2 (C) genes
(see Table 1 for accession numbers of viral genes) using L2000 according to manufacturer’s instructions. Note that the Pol II constructs in use also
give rise to expression of second reading frames in the NS, M and PB1 genes (NS2, M2, PB1-F2). 48 h post transfection cells were stimulated with
human IFNb (500 U/ml) for 15 minutes. Total protein lysates were subjected to Western blot analysis using anti-phospho-STAT1, anti-phospho-
STAT2, anti-STAT1 antibodies. Expression of influenza viral proteins was monitored with antibodies against NP, M1, NS1, PA, PB1 or PB2. (E) HEK293
cells were infected with the human influenza virus PR8 (H1N1) (MOI=5) for the indicated time points and were subsequently stimulated for 15 min
with either human IFNb at a concentration of 100 U/ml. Cell lysates were subjected to Western blots as described. (B, D, F) Quantification of relative
pSTAT1 and pSTAT2 band intensities in A, C and E using AIDA software and 2D densitometry (Fuji).
doi:10.1371/journal.ppat.1000196.g002
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(Figure 4A). While SOCS-3 mRNA is strongly and transiently
elevated in the early phases of infection, SOCS-1 gene transcription
is only significantly induced 15 h p.i.. Elevated SOCS-3 mRNA
levels were also observed in other host cell types, such as HUVEC
starting 3 h p.i. (Figure S1A). Although elevation of SOCS-3 mRNA
levels in infected cells was rather transient, there appears to be a
robust induction on protein level (Figure 4C). First detected at 4 h
p.i., SOCS-3 protein levels increased and stayed on a high level
throughout the observation period. Strikingly, expression kinetics of
the SOCS-3 protein perfectly matched the kinetics of virus-induced
inhibition of STAT1 phosphorylation (Figure 4C), indicating that
both processes are functionally linked.
Early induction of SOCS-3 gene transcription is not
indirectly mediated by IFNb
Virus mediated SOCS-3 gene induction at early stages of infection
(Figures 4A, 4C and S1A) appeared to occur concomitant with an
immediate and strong induction of IFNb (Figures 4B and S1D). This
prompted us to analyze whether SOCS-3 transcription might be
induced due to an auto- or paracrine action of IFNbexpressed during
infection. A549 cells were stimulated with IFNb for different time
points and SOCS-3 gene induction was measured by qRT-PCR
(Figure 4D). As a control we monitored expression of 29,5 9 -
oligoadenylate synthetase (OAS1) and MxA, genes that are typically
induced by IFNb. While OAS1 and MxA mRNAs were readily
upregulated upon IFNb treatment SOCS-3 mRNA was not
significantly elevated (Figure 4D). Similar results were obtained from
HUVECstimulatedwithIFNb(FigureS1E).Tofurtherconfirmthese
results we knocked down the IFNAR in A549-cells by an siRNA
approach. Although the knock down was efficient and leads to more
than 60% inhibition of IFNb induced STAT1 phosphorylation
(Figure 4E), the induction of SOCS-3 expression was not impaired
(Figure 4F). SOCS-3 levels in the knock down cells were similar
compared to wildtype cells and even higher than in the vector control
(Figure4F).Theseresultsareconsistentwithdatagainedfromprevious
experiments in Vero cells (Figure 1E) and indicate that neither
inductionofSOCS-3mRNAnorinhibitionofSTATphosphorylation
is dependent on virus-induced type I IFN expression.
Viral 59 triphosphate RNA is the major inducer of SOCS-3
gene transcription and causes reduced STAT1
phosphorylation
Since accumulation of viral RNA in infected cells is a potent
inducer of antiviral gene expression we investigated its ability to
induce SOCS-3 gene transcription. As a source for viral RNA,
Figure 3. Phosphatases do not mediate inhibition of IFNb-induced STAT1 phosphorylation in infected cells. (A) Vero cells were infected
for 10 h with PR8 (MOI=5) or left uninfected. Prior stimulation with human IFNb (500 U/ml for 15 min), cells were treated for 10 min with sodium
vanadate at concentrations indicated. Cells were harvested and protein lysates were subjected to Western blot analysis using anti-phospho-STAT1
and anti-STAT1 antibody. H2O2: was used as a control for solvent conditions. (B) Quantification of band intensities in (A). To visualize the effect of
sodium vanadate on the STAT1 phosphorylation in infected and uninfected cells, band intensities of IFNb stimulated samples were determined
relative to background. Linear regression was calculated using the Excel software (Microsoft) (s=slope of the regression line). (C) Phosphatase activity
in A549 cells infected wit PR8 (MOI=5) was determined using tyrosine phosphatase assay (Promega) according to manufacturers instructions. For
measurement of newly generated free phosphate two different phosphorylated pseudosubstrates (peptide 1 and peptide 2) were used.
doi:10.1371/journal.ppat.1000196.g003
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RNA from these cells was isolated. RNA from uninfected A549
cells served as a negative control. Different amounts of these RNAs
were used for stimulation of A549 cells for 3 h (Figures 5A, 5B and
5C). Transfection of RNA from uninfected cells did not result in
an increase of SOCS-1 or SOCS-3 gene transcription (Figure 5A)
or IFNb induction as a control (Figure 5B). However, transfection
of RNA from virally infected cells led to strongly elevated SOCS-3
mRNA amounts while SOCS-1 mRNA is only induced weakly
(Figure 5A). This dose dependent induction of SOCS-3 by
stimulation with increasing amounts of RNA from infected cells
corresponds with a gradual decrease in the ability of this RNA to
induce or potentiate STAT1/2 phosphorylation (Figure 5C).
In contrast to cellular RNA, influenza viral RNA carries a
triphosphategroup atits 59 terminus thatwas previouslyshowntobe
a major pathogen pattern that triggers cellular signaling [46]. To
verifythat indeed theviral 59 triphosphate RNA inthe pool ofRNAs
from infected cells is the major trigger for induction of SOCS-3
expression, RNA from infected or uninfected cells was treated with
phosphatase to remove the 59 triphosphate termini prior to
stimulation of A549 cells (Figure 5E and 5F). The dephosphorylated
viral RNAwas only poorly capable to induce SOCS-3(Figure 5E) or
IFNb (Figure 5F) mRNA expression. In addition, poly(I:C) was
transfected to mimic action of double-stranded (ds) RNA (Figure 5E
and5F,rightbars).However,thedsRNAanalogshowedsurprisingly




synthesized IFNb. In order to do so, cells were stimulated with viral
RNAaftertreatmentwiththeproteinsynthesisinhibitoranisomycinat
two different concentrations (Figure 5G). SOCS-3 mRNA was still
induced to the same extent in the presence of the protein synthesis
inhibitor, providing the ultimate proof that de novo protein synthesis is
not required for SOCS-3 induction.
SOCS-3 gene transcription involves the NF-kB signaling
pathway
So far, our data suggest that influenza virus-induced transcrip-
tional upregulation of the SOCS-3 gene is not mediated by the
Figure 4. Influenza A virus results in early SOCS-3 gene induction in an IFNb-independent manner. A549 cells were infected with PR8
(MOI=5) (A, B, C) or stimulated with 100 U/ml human IFNb (D) for the indicated time points. (F) A549 cells stably expressing IFNAR II-1 mRNA specific
shRNA or control empty vector were infected with PR8 (MOI=5) for 3 hours. Cells were lysed and RNA was subjected to reverse transcription. cDNA
was analyzed in quantitative real time PCR to assess mRNA amounts of IFNb (B), SOCS-1 (A), SOCS-3, (A, D, F), OAS1 (D) or MxA (D). Equivalent mRNA
amounts were normalized to GAPDH mRNA levels and calculated as n-fold of the levels of untreated cells that were arbitrarily set as 1. To detect
SOCS-3 protein expression (C) cells were infected for time points indicated or left uninfected. Total cell lysate was subjected to Western blot analysis
using anti-SOCS-3 antibody. To allow better comparison of SOCS-3 protein expression and STAT1 phosphorylation phospho-STAT1 and STAT1
Western blots from figure 1A are shown again here. (E) To functionally test effective knock down of the IFNAR, A459 wild type, A549 vector control
cells or A549 cells stably expressing IFNAR II-1specific shRNA were stimulated with human IFNb (100 U/ml) for 15 min. Subsequently cells were lysed
and levels of phospho-STAT1 were determined by Western blotting using specific antibodies. In addition, the relative pSTAT1 band intensities were
quantified.
doi:10.1371/journal.ppat.1000196.g004
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directly induced through accumulation of viral RNA during
infection. This raises the question, which RNA-induced signaling
pathways are responsible for SOCS-3 expression. The MKK/p38
mitogen activated protein kinase (MAPK) pathway [47–49] as well
as the IkB kinase (IKK)/nuclear factor of kB (NF-kB) cascade
[50–52] are both known to be activated by RNA or influenza virus
infection and to be involved in the control of SOCS-3 expression.
To assess whether the MKK6/p38- or the IKK/NF-kB-module is
required for SOCS-3 gene induction, we generated A549 cell lines
expressing dominant negative forms of either MKK6 (MKK6Ala)
or IKK2 (IKK2KD) (Figure 6A to 6D). These mutants have been
previously shown to efficiently block p38 or NF-kB signaling,
respectively [52–54]. To monitor SOCS-3 gene induction, wild
type, vector or mutant expressing cell lines were infected with PR8
(Figure 6A) or stimulated with RNA from virally infected or
uninfected A549 cells (Figure 6C). Induction of IFNb mRNA was
monitored as a control (Figure 6B and 6D). While MKK6Ala
expression did not result in significant reduction of SOCS-3 in
either infected (Figure 6A) or RNA-stimulated cells (Figure 6C),
transcription is markedly reduced in IKK2KD expressing cell
lines. To obtain independent evidence for NF-kB dependence of
SOCS-3 gene transcription, A549 wild type cells were incubated
with the NF-kB specific inhibitor BAY 11-7085 prior to
stimulation with RNA from virally infected or uninfected A549
cells (Figure 6E). Again, IFNb mRNA levels were assessed for
control purposes (Figure 6F). Both, SOCS-3 and IFNb mRNA
levels were strongly reduced in BAY 11-7085 treated cells. This
indicates that virus-induced SOCS-3 expression strongly depends
on IKK2 and NF-kB activation, while the MKK6/p38 appears
not to play a prominent role.
To further verify that influenza virus induces SOCS-3 via an
RNA sensory pathway and in an NF-kB dependent manner we
infected cells with the influenza A virus mutant deficient for NS1
Figure 5. Viral 59 triphosphate RNA efficiently induces SOCS-3 expression. Total RNA from infected or uninfected A549 cells was isolated
and used for transfection of native A549 cells with L2000 according to manufacturer’s instructions (A–G). Transfection of RNA from infected cells
(‘‘viral RNA’’) serves as a mimic for vRNA accumulation in infected cells while total cellular RNA from uninfected cells (‘‘cellular RNA’’) was used asa
control. In (E and F) different amounts of poly (I:C) or RNA from infected or uninfected cells treated with phosphatase (CIAP) as indicated were
transfected using L2000. In (G) viral RNA transfected cells were additionally treated with DMSO (solvent) or the protein synthesis inhibitor anisomycin
(aniso.) at the concentrations indicated. (A, B, E, F, G) Cells were lysed 3 h post transfection and total RNA was reverse transcribed. cDNA was analyzed
in quantitative real time PCR to assess amounts of SOCS-1 (A), SOCS-3 (A, E, G) and IFNb (B, F) mRNA levels. Equivalent amounts of mRNA were
normalized to GAPDH mRNA levels and calculated as n-fold of untreated cells, arbitrarily set as 1. In (C) cells were treated as in (A) and (B) and
monitored for phospho-STAT1 and phospho-STAT2 levels in Western blot analysis. (D) Quantification of relative phospho-STAT1 and phospho-STAT2
band intensities in (C).
doi:10.1371/journal.ppat.1000196.g005
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RNA dependent signaling and NFkB activation [55]. Accordingly,
infection of cells with the mutant virus resulted in a more
pronounced and sustained, albeit delayed induction of SOCS-3
(Figure 6G) if compared to infection with the isogenic wild type,
that is a very poor inducer of SOCS-3 but still reasonably well
induces IFNb. Noteworthy, this isogenic wild type strain differs
from the PR8 wild type virus used in the other experiments shown
here (see Materials and Methods for details).
To analyze whether NF-kB activation is sufficient for SOCS-3
gene induction we stimulated cells with IL-1b (Figure S2A) or
TNFa (Figure S2B) that are both strong activators of the
transcription factor. While mRNA levels of IL-6, a strictly NF-
kB dependent cytokine, are strongly elevated, SOCS-3 gene
transcription is not significantly induced. Under the assumption
that these cytokines do not additionally induce counteracting
processes one can conclude that NF-kB is required, yet not
sufficient for the induction of SOCS-3. Thus viral induction of
SOCS-3 may require additional factors that are only active in
virus-infected cells. Furthermore, these results rule out a potential
role of virus-induced IL-1b or TNFa in the induction of SOCS-3.
This is supported by the observation that neither expression of IL-
Figure 6. SOCS-3 mRNA transcription is induced in an NF-kB dependent manner. A549 wt cells or A549 cells stably transduced with empty
vector, dominant negative MKK6Ala or IKK2KD were either infected with PR8 for 3 hours (MOI=5) (A and B) or with the influenza A virus mutant
DNS1 and the corresponding isogenic wild type virus (G and H) [74] or transfected for 3 hours with RNA from infected or uninfected A549 cells (C–F).
(E and F) A549 cells were treated with 40 mM of the NF-kB inhibitor BAY 11-7085 30 minutes prior transfection of RNA from infected (‘‘viral RNA’’) or
uninfected A549 wt cells (‘‘cellular RNA’’). In all experiments shown total RNA from target cells was isolated and reverse transcribed. cDNA was
subjected to quantitative real time PCR. mRNA levels of SOCS3 (A, C, E, G) or IFNb (B, D, F, H) were assed by specific primers.
doi:10.1371/journal.ppat.1000196.g006
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upon virus infection.
SOCS-3 knock out results in enhanced constitutive STAT1
phosphorylation, and enhanced virus-induced
expression of ISGs
To further assess a functional role of SOCS-3 in virus-induced
suppression of STAT1 phosphorylation we analyzed mouse cells
with a targeted deletion of the SOCS-3 gene [56]. Wild type and
SOCS-3 deficient mouse embryonic fibroblasts (MEF) were
infected for different time points with PR8. The time of infection
was prolonged in comparison to the infection of A549 cells
because the human PR8 replicates less efficiently in mouse than in
human cells. Following infection lysates of these cells were assessed
for STAT1 phosphorylation (Figure 7A). Both cell types showed
no phosphorylation of STAT1 in the uninfected state. In contrast,
infection of SOCS-3 knock out cells resulted in strongly elevated
phosphorylation of STAT1 in a sustained fashion. To rule out that
this STAT1 phosphorylation is due to altered secretion of IFNb or
Figure 7. Enhanced STAT1 phosphorylation in infected SOCS-3 deficient MEF correlates with elevated induction of IFNb-stimulated
genes. Wild type MEF and SOCS-3 knock out MEF were infected with PR8 (MOI=5) for the indicated times. Subsequently, cell lysates were analyzed
for STAT1 phosphorylation (A). For control of productive virus replication, cell lysates were analyzed for viral protein PB1 expression. In (E, F, G) wild
type and knock out cells were lysed at indicated time-points of infection. Subsequently RNA was subjected to reverse transcription. cDNA was
analyzed in quantitative real time PCR to assess mRNA amounts of three prototype type I IFN-stimulated genes, SP110 (E), interferon regulatory
factor-1 (IRF-1) (F) and OAS1 (G). Equivalent mRNA amounts were normalized to GAPDH mRNA levels and calculated as n-fold of the levels of
untreated cells that were arbitrarily set as 1. In (C) wild type MEF and knock out MEF were infected with PR8 (MOI=5) or left uninfected. Supernatants
were taken 6 p.i. and used for stimulation of wild type MEF for 15 minutes. As control wild type MEF were stimulated with 500 U/ml mouse IFNb for
15 minutes. Cells were harvested and analyzed for the amount of STAT1 and phospho-STAT1 in Western blot analysis by specific antibodies. In (B)
and (D) the relative band intensities of phospho-STAT1 of the blots in (A) and (C) were quantified as described.
doi:10.1371/journal.ppat.1000196.g007
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performed conditioned medium experiments (Figure 7C). MEF
wild type and MEF SOCS-3 deficient cells were infected for 6 h
and supernatants were subsequently harvested. Stimulation of
MEF wild type cells with these different supernatants for 15 min.
revealed no differences in STAT1 phosphorylation, indicating that
both infected cell types secrete similar amounts of IFNb and other
STAT1 activating cytokines. This is a strong indication that the
observed differences in virus-induced STAT phosphorylation are
directly due to the presence or absence of SOCS-3 in wild type
and knock out MEF, respectively. To answer the question whether
enhanced STAT phosphorylation in SOCS-3 deficient cells would
also lead to enhanced expression of ISGs, total RNA was isolated
at different time points p.i. from infected wild type and knock out
cells and monitored for induction of SP110, IRF-1 and OAS1
(Figure 7E, 7F and 7G). These genes are described as type I IFN-
induced genes [18]. Indeed mRNA levels of all three represen-
tative ISGs were elevated in SOCS-3 knock out versus wild type
cells at almost every time point during the course of infection. This
indicates that enhanced STAT1 phosphorylation and activation in
SOCS-3 deficient cells results in elevated expression of ISGs.
Efficiency of viral propagation is affected by SOCS-3
expression levels
The remaining question was, whether the elevated IFN-induced
gene response in knock out cells might also affect propagation of
influenza A viruses. Thus, both wild type and knock out cells were
infected with PR8 (Figure 8A) or the strain A/Victoria/3/75
(H3N2) (Figure 8B). Virus titers were assessed at different time
points post infection. Progeny virus titers from SOCS-3 knock out
cells were significantly reduced compared to titers from infected
Figure 8. Efficiency of influenza A virus replication is dependent on SOCS3 expression levels. Wild type MEF and SOCS-3 knock-out MEF
were infected with PR8 (MOI=0.01) (A) or A/Victoria/3/75 (MOI=0.001) (B) for the indicated times. In (C) A549 wt cells were transfected for 48 h with
150 nM human SOCS3 siRNA using Hiperfect according to manufacturers protocol and infected with PR8 (MOI=0.001) for 9 h. In (D) the highly
susceptible cell line HEK293 was transfected with either pSUPER empty vector or pSUPER-mSOCS-3 for 48 h. Subsequently cells were infected with
PR8 (MOI=0.001) for 9 h. For (A), (B), (C) and (D) progeny virus titers were determined from the supernatants of infected cells by means of plaque
assay. To determine the effect of over expressed SOCS-3 on STAT1 phosphorylation (E) A549 cells were treated as in (D) and infected with PR8
(MOI=5) and/or stimulated with human IFNb (100 U/ml). Cells were lysed and cell extracts were analyzed for levels of phosphorylated STAT1 and
over expressed mSOCS-3 using anti phospho-STAT1 and anti flag-antibody in Western blots. Effective of SOCS-3 knock down was determined by
Western blot (C, right). Cells were treated as in (C, left) and total cells lysates were analyzed for endogenous SOCS-3 protein levels using anti-SOCS-3
antibody in Western blot. (F) Quantification of relative pSTAT1 band intensities in (E).
doi:10.1371/journal.ppat.1000196.g008
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verify that the observed effects are really due to the lack of SOCS-
3, we used an siRNA approach to specifically knock down SOCS-
3 mRNA in A549 cells. Cells were transfected with 150 nM
siRNA for 48 h and SOCS-3 protein levels were compared to
control transfected samples (Figure 8C, right). Subsequently, cells
were infected and progeny virus titers were determined by plaque
assay (Figure 8C, left). Similar to the results gained from infected
knock out cells, knock down of SOCS-3 resulted in decreased virus
titers.
On the contrary, over-expression of SOCS-3 resulted in
elevated virus titers (Figure 8D) concomitant with an inhibition
of IFNb- or virus-induced STAT1 phosphorylation (Figure 8E).
Taken together the data indicate that in the absence of SOCS-
3, infection leads to a stronger activation of STAT1, resulting in
enhanced expression of ISGs and reduced virus titers. Vice versa,
over-expression of SOCS-3 leads to an inhibition of STAT1
activation and elevated virus titers, probably due to inhibited
expression of ISGs.
This highlights the important role of virus induced SOCS-3 to
limit the type I IFN-induced antiviral response program.
Discussion
The type I interferon (IFN) system is one of the most powerful
innate defenses of vertebrate cells, which limits replication and
spread of viral pathogens including avian and human influenza
viruses. Influenza virus propagation is sensitive to IFN activities
and therefore, like other viral pathogens, these viruses do not only
induce type I IFN but also antagonize the production and effects of
these cytokines at the same time [55]. For influenza A and B
viruses, this is accomplished through their non-structural NS1
proteins that are structurally related polypeptides of 26 kDa (A/
NS1) and 32 kDa (B/NS1), which are abundantly expressed in
infected cells [55]. NS1 proteins predominantly act on the level of
IFN gene induction in infected cells by obstructing RIG-I-
dependent signaling through interaction with cellular factor(s)
and/or sequestration of RNAs generated during virus replication
[1,2,57]. Some NS1 proteins were also described to inhibit the
maturation of cellular pre-mRNAs raising the possibility that this
activity additionally reduces production of IFNa/b in infected cells
[58,59]. While NS1 also interferes with the activity of some ISGs,
such as the dsRNA dependent kinase PKR [5,60], so far no type I
IFN antagonistic mechanism was described for influenza viruses
that act on the level of IFN signaling rather than gene induction.
Here we present data, showing that RNA-induced expression of
SOCS-3 in early phases of infection leads to a functional inhibition
of IFN-induced STAT activation and gene expression. This is a
novel mechanism by which influenza virus suppresses the antiviral
response of the host and paves the path to efficient virus
replication.
While it was reported in the literature that expression of SOCS
proteins can be induced upon stimulation with IFN [61] we could
not detect any significant gene induction by IFNb in A549 cells.
Instead we observed a significant up-regulation of SOCS-3 by viral
59 triphosphate RNA, indicating that gene induction occurs via
accumulation of vRNA during infection. This appears to occur
through the RNA-mediated activation of the IKK/NF-kB
pathway, most likely activated through engagement of the RNA
sensor RIG-I. At a first sight, this might appear controversial since
NF-kB activation is among the RIG-I-induced signaling responses
and NS1 was reported to inhibit this signaling pathway. However,
despite the action of NS1 it is well known that NF-kB is still
significantly activated upon influenza virus infection and many
NF-kB and IFNb dependent genes are still expressed. We
hypothesized previously that the incomplete inhibition conferred
by NS1 is an indication that the virus exploits the remaining
signaling activities for efficient replication [52,62,63]. The findings
described here, namely NF-kB dependent induction of SOCS-3
and limitation of type I IFN signaling responses, provide yet
another example how influenza viruses take advantage of NF-kB
activity.
While the data show that NF-kB is required for viral SOCS-3
induction, the factor appears not to be sufficient, since prototype
inducers of NF-kB, such as IL-1b or TNF-a would not induce
SOCS-3. Thus there seems to be the need of additional virus or
RNA-induced transcription factors. The most likely candidate
would be the constitutively expressed interferon regulatory factor 3
(IRF-3), that is known to be simultaneously activated with NF-kB
upon virus infection directly via the RIG-I RNA sensing pathway
without the need of type I IFN. Furthermore IRF-3 is a factor
suppressed by the NS1 protein.
Recently it was reported that IFN-induced gene expression
responses are potentiated in cells, which lack the NF-kB factors
p50 or p65 [64]. Although these authors described an inhibitory
binding of NF-kB transcription factors to some IFN-induced gene,
this mechanism might be cell type dependent since we could not
observe similar effects in the cell types used here (data not shown).
Thus, the underlying molecular mechanisms appear to be not fully
clear. It is striking that the effects described for p50 and p65 knock
out cells in these studies fully correlate with our observations in
SOCS-3 deficient cells. While in the latter case cells lack the IFNb
signaling inhibitor SOCS-3, the p50 and p65 knock out cells are
deficient for the factors required for SOCS-3 induction. Thus,
given the NF-kB dependent induction of SOCS-3 described in the
present manuscript, we provide an additional molecular mecha-
nism that may explain the phenomenon described by Wei et al.
[64].
First indications for beneficial effects of SOCS-3 gene
expression on viral replication came from studies using the HCV
core protein as a replacement for the influenza A viral NS1 in the
context of infections with a NS1 deficient influenza virus [33]. One
of the hallmark responses of HCV core expression is a rapid
induction of SOCS-3 expression. Given the role of SOCS-3
described here, it was not surprising that HCV core could partially
rescue growth of the NS1 deficient virus [33].
While this manuscript was in preparation it was demonstrated
by Pothlichet et al. that influenza A virus-induced SOCS-1 and
SOCS-3 upregulation requires a TLR-3-independent, RIG-I/
MAVS-dependent pathway [65]. Moreover, over-expression of
SOCS-1 and SOCS-3 in infected cells revealed that both
molecules inhibit antiviral responses. These studies are perfectly
complemented by our findings. Here we confirm involvement of
RIG-I/MAVS by showing that 59 triphosphate RNA, the ligand
for RIG-I, is a major inducer of SOCS-3. Furthermore, the
finding that dsRNA is only a weak inducer of SOCS-3 is also
consistent with the independence from the dsRNA sensor TLR-3.
The only discrepancy of this work and the study of Pothlichet et al.
is that they show a dependence on the type I IFN receptor. This
may be due to the different virus-strains and cell types used. It is
well known that the capability of type I IFNs to induce SOCS
proteins is strongly cell type specific [31]. While in some cell types
SOCS-3 expression appears to be type I IFN dependent (e.g. fetal
liver cells) [31] it is clearly independent of IFN in other cell types
[66]. Recently it was shown that SOCS-3 is not significantly
induced by IFNa in A549 cells [18], the major cell type used in
our study. Evidence that cell type specificities may be the cause of
discrepancy is additionally provided by the fact that Pothlichet et
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contrast the kinetics of the two proteins differ clearly in the cells we
used, with SOCS-3 being induced much earlier than SOCS-1 on
mRNA and protein level.
Finally, it should be stated that regardless whether SOCS-3 is
additionally induced by type I IFNs at a later stage of infection, it
is important that it can be induced earlier and in parallel to IFNb
directly by vRNA accumulation. This is supported by the finding
that IFNb and SOCS-3 induction occurs in parallel kinetics
(Figure 4A and 4B) while IFN-induced genes such as OAS1 and
MxA are only up-regulated later in a delayed and more sustained
fashion (Figure 4D). This makes a qualitative difference since the
blocking effect of SOCS-3 on IFNb signaling already kicks-in
during the first wave of IFNb action.
Taken together we describe here for the first time that at least
some influenza A virus strains are able to suppress type I IFN
signaling by a mechanism involving NF-kB dependent activation
of SOCS-3 expression, which negatively affects STAT phosphor-
ylation. This adds a new aspect to our knowledge of the strategies
used by influenza A virus to antagonize type I IFN responses.
Materials and Methods
Cell culture, viruses and infection conditions
Human influenza A/Puerto-Rico/8/34 (H1N1) (PR8) (Giessen
variant) and A/Victora/3/75 (H3N2) (Victoria) were originally
taken from the strain collection of the Institute of Virology,
Giessen, Germany. The human NS1 deficient influenza virus
mutant DNS1 and its isogenic wild type variant were propagated
and used as described earlier [7,67]. It should be noted that this
isogenic wild type strain as described by Garcia-Sastre et al. [68] is
different from the PR8 (Giessen variant) used in the other
experiments and in many previous studies [52,67]. While both
variants are of the PR8 Mount Sinai type they exhibit different
replication properties. The human alveolar epithelial cell line
A549 and the corresponding A549 IFNAR II-1 shRNA and A549-
nt-pLKO.1-2 cells (generated at the RKI, Berlin, Germany), as
well as the human embryonic kidney (HEK) cell line HEK293, the
green monkey epithelial cell line Vero and mouse embryonic
fibroblasts (MEF) were grown in Dulbecco’s minimal essential
medium (D-MEM). Madin-Darby canine kidney (MDCK) cells
were grown in minimal essential medium (MEM). All growth
media contained 10% heat-inactivated fetal bovine serum and
antibiotics. Human umbilical vein embryonic cells (HUVEC) were
grown in endothelial growth medium (EGM, Lonza). For
infection, cells were washed and infected with the multiplicity of
infection (MOI) as indicated in the figure legends. For infection
PBS/BA [PBS containing 0.2% bovine serum albumin (BSA),
1 mM MgCl2, 0.9 mM CaCl2, 100 U/ml penicillin, 0.1 mg/ml
streptomycin] and virus were incubated for 30 minutes at 37uC.
The supernatant was aspirated and cells were incubated with
specific medium containing 0.2% BSA and antibiotics. To score
for production of viral plaques the overlay was stained for 1 h
using 1 ml neutral red in PBS per well [69].
Stimulation of cells with cytokines and /or treatment
with sodium vanadate
To trigger JAK/STAT signaling cells were stimulated using
human IFNa/b or c as well as mouse IFNb. For stimulation of
A549 cells or HUVECs 100 U/ml human IFNa or human IFNb
was used. For stimulation of the green monkey epithelial cell line
Vero or HEK 293 cells 500 U/ml human IFNb was applied.
IFNc was always used in the concentration of 500 U/ml. Mouse
embryonic fibroblasts (MEF) were incubated with 100 U/ml
mouse IFNb. The different IFN were diluted in infection medium.
For stimulation after infection, viral supernatants were aspirated
and diluted cytokine was incubated for 15 minutes at 37uC. To
investigate the potential of other cytokines to induced SOCS-3
gene expression A549 cells were stimulated with 100 U/ml IL1b
or 20 ng/ml TNFa at 37uC for times indicated. After stimulation
cells were lysed and subjected to immune blotting.
To block the activity of phosphatases after infection with
influenza virus, sodium vanadate was used. Dilutions were
prepared using infection medium. Sodium vanadate was added
to the virus-containing infection medium at the time points
indicated. After 10 minutes of incubation IFNb, diluted in
infection medium, was added to the medium containing virus
and sodium vanadate. The cells were stimulated with IFNb for
15 minutes. Incubation with sodium vanadate started 25 min
before cells were lysed and subjected to Western blotting as
described.
For conditioned medium experiments wild type and SOCS-3
knock out MEF were infected with PR8 (MOI=5) for 10 h or left
uninfected. Supernatants were used for stimulation of MEF wild
type for 15 minutes. Cell lysates were subjected to Western blot
analysis.
Stimulation of cells with phosphorylated or
dephosphorylated viral or cellular RNA
To investigate the induction of SOCS-3 expression by viral
RNA, RNA isolated from infected or uninfected cells (control) was
used. A549 cells were infected with PR8 (MOI=5) or left mock
infected. 10 h post infection RNA was isolated using the RNeasy
mini Kit from Qiagen according to manufacturer’s instructions.
To dephosphorylate viral 59 triphosphate RNA, calf intestine
alkaline phosphatase (CIAP) (Fermentas) was used. Briefly, RNA
was isolated using Trizol according to manufacturer’s instructions.
For dephosphorylation the reaction mix was set up in a 50 ml
volume with 50 mg RNA, 25 U CIAP and 80 U RiboLock RNase
inhibitor (Fermentas) and was incubated for 3 h at 42uC.
Thereafter the RNA was isolated using the RNeasy mini Kit
from Qiagen. RNAs used as control were mock-treated replacing
CIAP by glycerol.
For stimulation, the different RNA species and analogues were
transfected using Lipofectamine 2000 (L2000) according to
manufacturer’s instruction (Invitrogen). In brief, L2000 was
incubated with OPTI-MEM for 5 minutes at room temperature;
different amounts of RNA were added and incubated for
additional 15 minutes. For stimulation of cells with cellular or
viral RNA 400 ml RNA-L2000 mix were added to 2 ml serum-free
medium. Cells were stimulated for 3 hours and subjected to either
Western blot analysis or quantitative real time PCR.
siRNA mediated knock down of human SOCS-3
For silencing SOCS-3 mRNA, A549 cells were transfected with
150 nM human SOCS-3 siRNA 48 h before infection using
Hiperfect (Qiagen) according to manufacturer’s instructions. In
brief, 150 nM siRNA was added to a mixture of D-MEM without
FCS/antibiotics and Hiperfect and incubated for 10 min at room
temperature. For transfection 400 ml of this mixture were added to
the cells. Subsequently cells were subjected to plaque assay analysis
or Western blot analysis. Control siRNA was purchased from
Qiagen. The sequences for the human SOCS-3 siRNA in use are:
human SOCS-3 siRNA sense 59- CCA AGA ACC UGC GCA
UCC AdTdT-39, human SOCS-3 siRNA anti-sense 59 - UGG
AUG CGC AGG UUC UUG GdTdT-39 ) (see Table 1 for
accession number of the human SOCS-3 gene).
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To determine whether tyrosine phosphatases become activated
upon infection with influenza virus a phosphatase assay using the
Tyrosine Phosphatase Assay System (Promega) was performed.
A459 cells were infected for 10 h (MOI=5) or left uninfected.
Cells were harvested in assay buffer (100 mM tris-HCl pH 5.2,
100 mM CaCl2, 100 mM MgCl2, 0.02% b-mercapto ethanol),
cracked by a single freeze/thaw step at 280uC and disrupted by
ultrasonic pulsing. Lysates were precleared from cell debris and
residual free phosphates according to the manufacturer’s instruc-
tion. Tyrosine phosphatase activity was measured by enzymatic
release of free phosphate of two given pseudosubstrates (phos-
phorylated peptides representing target sequences for the most
common tyrosine phosphatases). Quantification was performed in
comparison to a given standard according to the manufacturer’s
instruction.
Western blots
For Western blot analysis cells were lysed with RIPA [25 mM
Tris/HCl, pH 8.0, 137 mM NaCl, 10% Glycerol, 0.1% SDS,
0.5% NaDOC, 1% IgePal, 2 mM EDTA, pH 8.0, pyrophosphate
5 mgm l
21 aprotinin; 5 mgm l
21 leupeptin; 1 mM sodium vana-
date and 5 mM benzamidine] on ice for a minimum of
30 minutes. Supernatants were cleared by centrifugation in a
standard tabletop centrifuge (Eppendorf) at maximum speed.
Protein concentration was determined by Bradford assay.
The phosphorylated and unphosphorylated forms of STAT1
were detected using anti-STAT1 (Y701) antibody and anti-
STAT1 (BD Bioscience). An antibody directed against Y690 of
STAT2 was used for detection of the phosphorylated form of
STAT2 (Upstate). Antibodies to detect influenza viral proteins
were purchased from Serotec (NP, M1), Santa Cruz (PB1, PB2).
The anti-PA antibody was kindly provided by J. Ortin (Madrid/
Spain). A monoclonal antibody directed against the viral NS1 was
generated at the IMV, Muenster, Germany [70]. A monoclonal
anti-Myc-tag antibody to detect Myc-M1 was kindly provided by
Viktor Wixler. IMV, Muenster, Germany. All secondary antibod-
ies were purchased from Amersham and diluted 1:2500 in TBS-T.
Secondary antibodies were incubated for a minimum of
60 minutes at room temperature.
Reverse Transcription and quantitative real time PCR
To synthesize cDNA from cells, RNA was isolated using Qiagen
RNeasy mini kit according to manufacturer’s instruction. In brief,
cells were lysed in the presence of b-mercaptoethanol and lysates
were loaded to a column, washed and eluted in RNase- free water.
For reverse transcription 3 mg total RNA, 0.5 mg oligo dT primer
in a total volume of 12 ml were heated for 10 minutes at 70uC.
Enzyme mix was prepared (56Enzyme Buffer (Fermentas), water
and 500 mM dNTPs) and pre-warmed at 42uC for 2 minutes
before adding 535 U/100 ml RevertAid H
2 M-MuLV (Fermen-
tas).
Reverse transcription was performed at 42uC for 1 hour. The
enzyme was inactivated at 70uC for 10 minutes. Samples were
stored at 220uC or directly used in quantitative real-time PCR.
For analysis of gene expression relative quantification of the
DNA amount was applied. In order to do that gene expression of
the housekeeping gene GAPDH was determined. To ascertain
changes in expression of the gene of interest the differences
between expression of GAPDH and the gene of interest was
calculated using the 2
2DDCT method [71]. For quantitative real
time Brilliant QPCR SYBR Green Mastermix (Stratagene) was
used according to manufacturer’s instructions. The fragment of
interest was amplified in 40 cycles. The following primers were
used (see Table 1 for identity of the parental genes): human primer
pairs: GAPDH_fwd 59-GCA AAT TTC CAT GG CAC CGT39,
GAPDH_rev 59 - GCC CCA CTT GAT TTT GGA GG-39,
IFNb-fwd 59 - GGC CAT GAC CAA CAA GTG TCT CCT CC-
39, IFNb_rev 59 - GCG CTC AGT TTC GGA GGT AAC CTG
T-39, SOCS-1_fwd 59 - TTG CCT GGA ACC ATG TGG -39,
SOCS1_rev 59 - GGT CCT GGC CTCCAG ATA CAG -39,
SOCS-3_fwd 59 - GGA GTT CCT GGA CCA GTA CG-39,
SOCS-3_rev 59 - TTC TTG TGC TTG TGC CAT GT -39,
OAS1_fwd 59 - GAT CTC AGA AAT ACC CCA GCC A-3,
OAS-1_rev 59 - AGC TAC CTC GGA AGC ACC TT-39,
MxA_fwd 59 -GTT TCC GAA GTG GAC ATC GCA-3, MxA
rev 5-GAA GGG CAA CTC CTG ACA GT-3, IL1b_fwd 59 -
GCG GCC AGG ATA TTT TAA CTG ACT TC-3, IL1b_rev 59
-TCC ACA TTC AGC ACA GGA CTC TC-3, IL6_fwd 59 -
AGA GGC ACT GGC AGA AAA CAA C-3, IL6_rev 59 -AGG
CAA GTC TCC TCA TTG AAT CC-39 and murine primer
pairs: GAPDH_fwd 59 - ACA GCC GCA TCT TCT TGT GCA
GTG-39, GAPDH_rev 59 - GGC CTT GAC TGT GCC GTT
GAA TTT-3, SOCS-3_fwd 59 - GGG TGG CAA AGA AAA
GGA G-39, SOCS-3_rev 59 - GTT GAG CGT CAA GAC CCA
GT-3, IRF-1_fwd 59 - ATG CCA ATC ACT CGA ATG CG-39,
IRF-1_rev 59 - TTG TAT CGG CCT GTG TGA ATG-3,
SP110_fwd 59 - TAG GGA AGC ATC CAA AAC GAA TG-39,
SP110_rev 59 - CCT GGG GCT CTT GTT CAT CAC-39,
OAS1_fwd 59 - GTC AAT GTC GTG TGT GAT TT-39,
OAS1_rev 59 -CTC CCC GTC GGT TTA ACT GA-39.
Retroviral vectors and retroviral transduction
The pCFG5-EGZ retroviral vector used for transfection [72] as
well as the constructs to express dominant negative MKK6
(MKK6Ala) or IKK2 (IKK2KD) have been described earlier
[52,73]. The Phoenix amphotropic retroviral producer cells (a gift
Table 1. Accession numbers of human, murine and viral






OAS1 isoform 3 NM_001032409.1
OAS1 isoform 2 NM_002534.2














Influenza A Virus Inhibits Type I IFN Signaling
PLoS Pathogens | www.plospathogens.org 13 November 2008 | Volume 4 | Issue 11 | e1000196from G. Nolan, Stanford, CA) [74] were cultured in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum, 100
units/ml penicillin and 100 mg/ml streptomycin. Generation of
MKK6Ala or IKKKD expressing producer cells as well as
transduction of A549 cells to stably express these transgenes was
performed as previously described [52,53].
Supporting Information
Figure S1 Infection of HUVEC results in inhibition of STAT1
phosphorylation and IFNb independent SOCS-3 gene transcrip-
tion. HUVEC were infected with PR8 (MOI=5) (A, B, D) or
stimulated with 100 U/ml IFNb (E) for time points indicated. To
assess the mRNA levels of SOCS-3 (A, E), IFNb (B) and MxA (E)
RNA was reverse transcribed and cDNA was subjected to
quantitative real time PCR. Equivalent mRNA amounts were
normalized to endogenous GAPDH and calculated as n-fold of
untreated cells that were arbitrarily set as 1. To assess the amount
of phosphorylated STAT1 (B) A549 cells were infected with PR8
(MOI=5) for time points indicated. Total cells lysate was
subjected to Western Blot analysis using anti-phospho-STAT1,
anti-STAT1 antibodies. To assess effective viral replication viral
NS1 was detected using an anti-NS1 antibody. (C) Quantification
of relative band intensities of (B) using AIDA software and 2D
densitometry (Fuji).
Found at: doi:10.1371/journal.ppat.1000196.s001 (1.22 MB TIF)
Figure S2 IL1b and TNFa do not affect induction of SOCS-3
gene transcription. A549 wt cells were stimulated with 100 U/ml
IL1b (A), 20 ng/ml TNFa (B) or infected with PR8 (MOI=5) (C)
for time points indicated. Cells were lysed, and RNA was subjected
to reverse transcription. cDNA was analyzed in quantitative real
time PCR to assess mRNA amounts of SOCS-3 and IL6 (A and B)
or IL1b (C). Equivalent mRNA amounts were normalized to
GAPDH mRNA levels and calculated as n-fold of the levels of
untreated cells that were arbitrarily set as 1.
Found at: doi:10.1371/journal.ppat.1000196.s002 (4.87 MB TIF)
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